Thompson Siegel & Walmsley’s GSK GSK Stock Holding History

Thompson Siegel & Walmsley’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-97,280	Closed	-$5.29M	–	567
2022 Q2	$5.29M	Sell	97,280 -70,720	-42%	-$3.85M	0.09%	190
2022 Q1	$9.15M	Buy	168,000 +20,600	+14%	+$1.12M	0.13%	161
2021 Q4	$8.13M	Buy	147,400 +12,000	+9%	+$661K	0.11%	170
2021 Q3	$6.47M	Buy	135,400 +27,160	+25%	+$1.3M	0.09%	182
2021 Q2	$5.39M	Buy	108,240 +81,120	+299%	+$4.04M	0.07%	191
2021 Q1	$1.21M	Sell	27,120 -770	-3%	-$34.4K	0.02%	236
2020 Q4	$1.28M	Hold	27,890	–	–	0.02%	230
2020 Q3	$1.31M	Hold	27,890	–	–	0.03%	220
2020 Q2	$1.42M	Buy	27,890 +27,120	+3,522%	+$1.38M	0.03%	213
2020 Q1	$36K	Hold	770	–	–	﹤0.01%	428
2019 Q4	$45K	Hold	770	–	–	﹤0.01%	496
2019 Q3	$41K	Hold	770	–	–	﹤0.01%	521
2019 Q2	$39K	Hold	770	–	–	﹤0.01%	527
2019 Q1	$40K	Hold	770	–	–	﹤0.01%	511
2018 Q4	$37K	Hold	770	–	–	﹤0.01%	512
2018 Q3	$39K	Hold	770	–	–	﹤0.01%	548
2018 Q2	$39K	Hold	770	–	–	﹤0.01%	557
2018 Q1	$38K	Hold	770	–	–	﹤0.01%	550
2017 Q4	$34K	Hold	770	–	–	﹤0.01%	585
2017 Q3	$39K	Sell	770 -640	-45%	-$32.4K	﹤0.01%	555
2017 Q2	$76K	Hold	1,410	–	–	﹤0.01%	490
2017 Q1	$74K	Buy	1,410 +640	+83%	+$33.6K	﹤0.01%	516
2016 Q4	$37K	Hold	770	–	–	﹤0.01%	525
2016 Q3	$42K	Hold	770	–	–	﹤0.01%	498
2016 Q2	$42K	Hold	770	–	–	﹤0.01%	477
2016 Q1	$39K	Sell	770 -4,396	-85%	-$223K	﹤0.01%	467
2015 Q4	$261K	Hold	5,166	–	–	﹤0.01%	358
2015 Q3	$248K	Sell	5,166 -40	-0.8%	-$1.92K	﹤0.01%	366
2015 Q2	$271K	Sell	5,206 -59	-1%	-$3.07K	﹤0.01%	364
2015 Q1	$304K	Sell	5,265 -1,141	-18%	-$65.9K	0.01%	361
2014 Q4	$342K	Sell	6,406 -112	-2%	-$5.98K	0.01%	358
2014 Q3	$375K	Sell	6,518 -240	-4%	-$13.8K	0.01%	339
2014 Q2	$452K	Hold	6,758	–	–	0.01%	330
2014 Q1	$451K	Hold	6,758	–	–	0.01%	334
2013 Q4	$451K	Hold	6,758	–	–	0.01%	336
2013 Q3	$424K	Hold	6,758	–	–	0.01%	339
2013 Q2	$422K	Buy	+6,758	New	+$422K	0.01%	343